The hepatitis C virus (HCV) primarily affects the liver. The treatment for HCV has improved now because of the launch of new therapies like Sovaldi, Harvoni and Viekira Pak with improved efficiency, tolerability and shorter duration of treatment. Many new therapies are under clinical trials for achieving more efficiency and cure rate. HCV mainly spreads through blood transfusion and poorly sterilized medical equipments resulting in liver cirrhosis and even leading to liver failure.

The main reason that many patients go undiagnosed and not aware of the infection is because it affects very slowly and its symptoms take years to be recognized but today initiatives like proper blood screening has helped in recognizing more patients. Regular alcohol consumption and taking of drugs are also the reasons for getting caught by the infection. Manu people use to skip the therapy till some years back because of long duration of treatment and being very costly but the market is increasing due to the coming of more effective therapies and reimbursement policies.

As per the report “HCV Market: 2016 Edition” by Koncept Analytics, the demand for HCV will be driven by comfort of reimbursement, growth in the number of patients, smaller period of drug treatment, increasing healthcare expenditure and treatment of warehoused patients. Some of the noteworthy trends and developments of this industry are launch of interferon free regimen and development of new products. However, the expansion of HCV market is hindered by regulatory risks, patent risk, risk associated with drug development and increased competition.

The report by Koncept Analytics presents an in-depth analysis of the global market along with a focus on all major regions. A thorough analysis has been conducted on key market players covering their business overview, product portfolio, financial overview and business strategies.

By combining SPSS Inc.’s data integration and analysis capabilities with our relevant findings, we have predicted the future growth of the industry. We employed various significant variables that have an impact on this industry and created regression models with SPSS Base to determine the future direction of the industry. Before deploying the regression model, the relationship between several independent or predictor variables and the dependent variable was analyzed using standard SPSS output, including charts, tables and tests.

List of Charts

Types of Hepatitis C Virus (HCV)
Natural History of HCV Infection
Global HCV Market by Value (2011-2015)
HCV Genotype 1 Patients in Emerging Markets (2015)
Global Deaths Due to HCV (2010-2014)
The US HCV Market by Value (2011-2015)
The US HCV Market Dynamics (2014)
Total Estimated HCV Patients to be treated in US (2015)
Total Estimated Genotype1 Patients to be treated in the US (2015)
Estimated HCV Patients to be treated in the US (2016E–2029E)
Patients Initiating Treated with Sofosbuvir Based Regimen (2015)
HCV Patients Initiated Treatment with Sofosbuvir based Regimen by Genotype (2015)
HCV Patients Initiated Treatment with Sofosbuvir based Regimen by Fibrosis Score (2015)
HCV Patients Initiated Treatment with Sofosbuvir based Regimen by Patient Type (2015)
EU HCV Market by Value (2011-2015)
Estimated Number of Patients to be treated in EU (2016E – 2029E)
Japanese HCV Market by Value (2011-2015)
Estimated Number of Patients to be treated in Japan (2016E–2029E)
Rest of World HCV Market by Value (2011-2015)
Reimbursement Situation (2015)
Global GDP Growth (2006-2014)
Global Healthcare Expenditure (2007-2014)
Frequency of Patients Warehoused Currently by Doctors (2014)
Warehoused Patients Expected to be treated in 2015
Warehoused Patients Expected to be treated in 2016
Global Ageing Population (2006-2014)
Mix of Doctors in Survey (2014)
Frequency of New Patients Treated per Month (2014)
Newly Identified Patients per Year (2015E–2029E)
Percentage of New Diagnosed Patients (2015E – 2029E)
Global Market Share of HCV and HBV (2014)
Global Market Share of HCV and HBV (2020E)
Global Sales of Sovaldi, Harvoni and Viekira Pak (2015)
The US Market Share of Viekira and Harvoni (2014)
Factors Affecting the Growth of Viekira (2014)
Factors affecting while Prescription of Harvoni and Viekira (2014)
The US Market Share by Company (2016E)
Gilead Revenue and Net Income (2010-2014)
AbbVie Revenue and Net Income (2010-2014)
J&J’s Consumer Sales by Segment (2014)
J&J’s Pharmaceutical Sales by Segment (2014)
Global Medical Devices Sales by Segment (2014)
Johnson & Johnson Revenue and Net Income (2010-2014)
J&J’s Research & Development Expenses by Segment (2013-2014)
Bristol Myers Squibb Revenue and Net Income (2010-2014)
Bristol-Myers Revenue by Region (2014)
Global HCV Market Forecast (2014-2019E)

List of Tables

Different Ways of Transmission of HCV
Global HCV Prevalence by Region (2014)
Summary of Survey Population
Market Share Based on Contracted Lives
Clinical Factors Affecting Market Share of AbbVie Vs. Gilead (2014)
Cure Rates with New Direct Acting anti-Viral - DAA (2014)
Viekira Pak Pill Order
Future Regimens of Gilead, AbbVie and Merck
Dependent & Independent Variables (2011-2015)
Correlation Matrix
Model Summary – Coefficient of Determination
Regression Coefficients Output



For more Information:
http://www.konceptanalytics.com/Researchreport/china-spirits-market-report-2016-edition-276.aspx

Koncept Analytics
Vikas Gupta
(Business Development Manager)
FFCS-36, Ansal Plaza
Vaishali, Ghaziabad
U.P - 201010
Tele: +91-120-4130959
Mobile: +91-9811715635
Mail ID – [email protected]


Koncept Analytics is a market research company. We are in the field of Market Research from last 10 Years. We do research in telecommunication, healthcare, pharmaceutical, financial services, energy, technology, real estate, logistics, food & beverages and media sectors. For more information:
http://www.konceptanalytics.com